Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
Keyword(s):
AbstractWe show that ivermectin, an FDA-approved anti-parasitic drug, effectively inhibits infection with hepatitis E virus (HEV) genotypes 1 and 3 in a range of cell culture models, including hepatic and extrahepatic cells. Long-term treatment showed no clear evidence of the development of drug resistance. Gene silencing of importin-α1, a cellular target of ivermectin and a key member of the host nuclear transport complex, inhibited viral replication and largely abolished the anti-HEV effect of ivermectin.
2020 ◽
Vol 52
(8)
◽
pp. 926-927
◽
2021 ◽
pp. 106383
Keyword(s):
2001 ◽
Vol 120
(5)
◽
pp. A115-A115
◽
2004 ◽
Vol 171
(4S)
◽
pp. 424-424
◽
2006 ◽
Vol 5
(1)
◽
pp. 127-127
Keyword(s):